Is Natural Alchemist Safe? FDA Warning Letter Review (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on October 31, 2017
Executive Summary
The FDA issued a warning letter to Natural Alchemist on October 31, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Los Angeles District Office.
Detailed Analysis
False Claims and Regulatory Violations
“Cannabinoids are found to have particular application . . . in limiting neurological damage following stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.”
“Study: Cannabinoids a Potential Treatment Option for Chemotherapy-Induced Hearing Loss”
“ [C]annabis plant, enriched with CBD, can be used for treating diseases like rheumatoid arthritis, colitis, liver inflammation, heart disease and diabetes.”
Potential Health Risks
“I was pleasantly surprised to find that CBD helped my arthritis…I have shared with my son and he states he is a big believer in CBD for . . . TBI [traumatic brain injury] after being acquainted with military personnel who have tried it.”
Regulatory Context
This warning letter is part of the FDA's enforcement of federal regulations.
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Natural Alchemist?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Natural Alchemist products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Natural Alchemist products?
- If you have used products from Natural Alchemist and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter